Finance

Beta
Lists
VCNX:OTCMKTS
Vaccinex Inc
1,00 $
0,00%
(0,00) 1D
29 մյս, 15:09:26 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VCNX...
Mkt. cap
2,68 մլն
Avg. vol.
2,74 հզր
Volume
65,00
52-wk high
1,50 $
52-wk low
0,31 $
Beta
0,89
Shares outstanding
2,68 մլն
No. of employees
25
Mkt. cap
2,68 մլն
Avg. vol.
2,74 հզր
Volume
65,00
52-wk high
1,50 $
52-wk low
0,31 $
Beta
0,89
Shares outstanding
2,68 մլն
No. of employees
25
News stories
From sources across the web
About Vaccinex Inc
CEO-
Employees25
Founded2001
Headquarters-
Sector-
Websitevaccinex.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2024 թ. մրտ
2024 թ. հնս
2024 թ. սեպ
2024 թ. դեկ
Revenue
104,00 հզր
232,00 հզր
52,00 հզր
213,00 հզր
Cost of goods sold
3,38 մլն
3,86 մլն
-
12,54 մլն
Cost of revenue
3,38 մլն
3,86 մլն
-
12,54 մլն
Research and development expenses
-
-
3,16 մլն
-10,41 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,80 մլն
2,09 մլն
1,44 մլն
1,47 մլն
Operating expense
1,80 մլն
2,09 մլն
4,60 մլն
-8,94 մլն
Total operating expenses
5,18 մլն
5,95 մլն
4,60 մլն
3,60 մլն
Operating income
-5,07 մլն
-5,72 մլն
-4,55 մլն
-3,39 մլն
Other non operating income
1,18 մլն
91,00 հզր
-1,18 մլն
15,00 հզր
EBT including unusual items
-3,90 մլն
-5,63 մլն
-5,73 մլն
-3,37 մլն
EBT excluding unusual items
-3,90 մլն
-5,63 մլն
-5,73 մլն
-3,37 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,90 մլն
-5,63 մլն
-5,73 մլն
-3,37 մլն
Net profit margin
-3 747,12%
-2 427,16%
-11 023,08%
-1 584,04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-2,00 հզր
Net interest expenses
-
-
-
-2,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,05 մլն
-5,70 մլն
-4,53 մլն
-3,37 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer